„Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway“. Nigerian Journal of Physiological Sciences 40, no. 2 (April 11, 2026). Zugegriffen April 12, 2026. https://ojshostng.com/index.php/njphysiologicalsciences/article/view/4001.